# A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects

> **NCT05895565** · PHASE1 · COMPLETED · sponsor: **Pulmongene Ltd.** · enrollment: 29 (actual)

## Conditions studied

- IPF

## Interventions

- **DRUG:** PMG1015
- **DRUG:** PMG1015 placebo

## Key facts

- **NCT ID:** NCT05895565
- **Lead sponsor:** Pulmongene Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-19
- **Primary completion:** 2025-02-07
- **Final completion:** 2025-02-07
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05895565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05895565, "A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05895565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*